| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 34,094 | 31,514 | 32,373 | 29,934 | | Cost of Revenue | (15,064) | 15,064 |
-
|
-
| | | Gross Profit | 49,158 | 16,450 | 32,373 | 29,934 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 9,222 | 4,880 | 6,597 | 10,021 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 19,419 | (6,246) | 6,246 | 6,071 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 20,517 | 17,816 | 19,530 | 13,842 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 21,798 | 54 |
-
| 8 | | Earnings Before Interest And Taxes | 20,511 | 17,870 | 19,530 | 13,850 | | Interest Expense | 9,390 | 9,431 | 9,463 | 10,773 | | Income Before Tax | 11,121 | 8,439 | 10,067 | 3,078 | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 11,121 | 8,439 | 10,067 | 3,078 | | | Non-recurring Events | | Discontinued Operations | (736) | (581) | 650 | (1,167) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 10,355 | 7,858 | 10,717 | 1,910 | | Preferred Stock And Other Adjustments | 19 | (12) | (7) |
-
| | | Net Income Applicable To Common Shares | $10,374 | $7,846 | $10,710 | $1,910 |
|
0.20% Nasdaq 
0.06 (0.62%) 
Income Statement
